In contrast, ENHO exhibited negative co-expression with MHC class I-related genes (TAP1, TAP2, and TAPBP), which may reflect a tumor-driven mechanism aimed at evading cytotoxic T cell-mediated immune surveillance. This evidence concerns the gene TAP2 and neoplasm.